Multiple Sclerosis: Does treatment reduce long-term disability progression?

多发性硬化症：治疗是否可以减少长期残疾进展？

• 批准号: nhmrc : 1032484
• 负责人: Prof Danny Liew
• 金额: $ 23.28万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2012
• 资助国家: 澳大利亚
• 起止时间: 2012-01-01 至 2014-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/multiple-sclerosis-does-disability-progression/110851
• 关键词: Multiple; Sclerosis; Does; treatment; reduce

Multiple Sclerosis is an illness affecting more than 20,000 Australians, and causes significant disability and social disruption in most sufferers. It is an illness which progresses over decades, and this makes it difficult to accurately determine the best treatment strategies. We propose to use a registry that has followed more than 16,000 people with MS globally to examine which treatment strategies have provided the highest benefit/risk ratio in these patients, given the great variability of disease severity seen.

多发性硬化症是一种影响2万多澳大利亚人的疾病，大多数患者会导致严重的残疾和社会混乱。这是一种持续数十年的疾病，这使得准确确定最佳治疗策略变得困难。考虑到疾病严重程度的巨大差异，我们建议使用全球超过16,000名MS患者的注册表来检查哪些治疗策略在这些患者中提供了最高的获益/风险比。